FBRX Forte Biosciences, Inc.

Fundamentals / CIK 0001419041 / USD

Forte Biosciences, Inc. reported $205.7M in total assets and a net loss of $87.94M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FBRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$25.10M$12.55M$0-$66.40MFY 2016 Revenue: $49KFY 2016 Net Income: -$33.48M2016FY 2017 Revenue: $41KFY 2017 Net Income: -$38.93M2017FY 2018 Revenue: $18.04MFY 2018 Net Income: -$48.95M2018FY 2019 Revenue: $36KFY 2019 Net Income: -$4.07M2019FY 2020 Net Income: -$46.49M2020FY 2021 Net Income: -$21.71M2021FY 2022 Net Income: -$13.88M2022FY 2023 Net Income: -$31.48M2023FY 2024 Net Income: -$35.48M2024FY 2025 Net Income: -$69.38M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- $36K $18.04M $41K $49K
Research & Development $57.65M $20.71M $21.86M $5.59M $13.85M $10.00M $45.30M $51.08M $29.11M $27.22M
Total Operating Expenses $70.66M $36.60M $32.49M $13.90M $21.49M $46.28M $4.06M $63.89M $37.67M $31.74M
Operating Income -$70.66M -$36.60M -$32.49M -$13.90M -$21.49M -$46.28M -$4.06M -$45.85M -$37.63M -$31.69M
EBITDA -$70.59M -$36.56M -$32.48M -- -$21.45M -$46.23M -$4.05M -$45.23M -$37.34M -$31.43M
Interest Income -- -- -- -- -- -- $1.56M $1.53M $595K $215K
Interest Expense -- -- -- -- -- -- $3.82M $2.93M $1.93M $2.05M
Income Before Tax -$68.34M -$35.48M -$31.48M -- -- -- -$63.52M -$47.26M -$38.93M -$33.48M
Income Tax Expense $1.04M $0 -- -- -- -- $1.0K $1.70M $1.0K $1.0K
Net Income -$69.38M -$35.48M -$31.48M -$13.88M -$21.71M -$46.49M -$4.07M -$48.95M -$38.93M -$33.48M
Basic EPS -$4.71 -$12.17 -$24.92 -$20.00 -$38.75 -$158.00 -$48.25 -$61.00 -$66.50 -$380.50
Diluted EPS -$4.71 -$12.17 -$24.92 -$20.00 -$38.75 -$158.00 -$48.25 -$61.00 -$66.50 -$380.50
Basic Shares Outstanding -- -- -- 695.3K 558.7K 294.4K 84.3K 802.4K 584.3K 88.0K
Diluted Shares Outstanding -- -- -- 695.3K 558.7K 294.4K 84.3K 802.4K 584.3K 88.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Research & Development $22.19M $20.32M $21.59M $15.05M $8.47M $12.54M $5.08M $5.72M
Total Operating Expenses $24.60M $22.44M $24.57M $18.38M $11.58M $16.12M $7.35M $8.63M
Operating Income -$24.60M -$22.44M -$24.57M -$18.38M -$11.58M -$16.12M -$7.35M -$8.63M
EBITDA -$24.58M -$22.42M -$24.55M -$18.37M -$11.56M -$16.11M -$7.34M -$8.62M
Income Before Tax -$23.14M -$21.76M -- -- -$11.25M -$15.66M -- --
Income Tax Expense $193K $373K -- -- $0 $0 -- --
Net Income -$23.33M -$22.14M -$24.79M -$17.68M -$11.25M -$15.66M -$7.16M -$8.39M
Basic EPS -$0.97 -$1.24 -- -$0.99 -$0.96 -$1.37 -- -$4.54
Diluted EPS -$0.97 -$1.24 -- -$0.99 -$0.96 -$1.37 -- -$4.54

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $76.96M $22.24M $37.12M $41.10M $42.04M $58.77M $6.94M $40.81M $35.93M $5.51M
Short-Term Investments $0 $36.12M -- $0 -- -- $12.84M $55.27M $52.79M $25.73M
Cash & Short-Term Investments $76.96M $58.40M $37.12M $41.10M $42.04M $58.77M $21.80M $96.10M $88.72M $31.25M
Total Current Assets $80.59M $61.35M $38.33M $41.51M $42.52M $59.90M $7.51M $97.75M $90.63M $32.46M
Property, Plant & Equipment, Net $129K $77K $109K -- -- $97K $152K $3.97M $1.22M $743K
Other Non-Current Assets $2.06M $138K $544K $486K $786K $1.24M $0 $1.36M $227K $2.15M
Total Non-Current Assets $2.19M $215K $653K $486K $786K $1.34M $152K $5.33M $1.44M $2.89M
Total Assets $82.78M $61.56M $38.98M $42.00M $43.31M $61.24M $7.66M $103.1M $92.07M $35.35M
Accounts Payable $9.99M $4.88M $1.42M $1.15M $946K $1.24M $1.57M $3.40M $1.95M $1.67M
Deferred Revenue (Current) -- -- -- -- -- -- -- $36K $36K $45K
Total Current Liabilities $20.75M $9.08M $3.67M $3.18M $1.76M $2.26M $1.91M $16.53M $17.33M $14.38M
Long-Term Debt -- -- -- -- -- -- -- $26.20M $3.62M $10.24M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- -- $36K $68K
Other Non-Current Liabilities $1.04M -- -- -- -- -- $81K -- -- --
Total Non-Current Liabilities $1.04M $0 $0 $0 $0 $0 $15.40M $28.40M $3.66M $13.97M
Total Liabilities $21.79M $9.08M $3.67M $3.18M $1.76M $2.26M $17.31M $44.94M $20.99M $28.36M
Total Debt (incl. Leases) -- -- -- -- -- -- $4.44M $26.20M $3.62M $10.24M
Common Stock $13K $6.0K $1.0K $21K $15K $13K $2.0K $23K $20K $2.0K
Retained Earnings -$223.4M -$154.0M -$118.5M -$87.04M -$73.17M -$51.46M -$4.97M -$215.9M -$166.9M -$128.0M
Accumulated Other Comp. Income $3.0K $11K $4.0K -- -- -- $10K -$23K -$34K --
Total Stockholders' Equity $60.99M $52.48M $35.31M $38.82M $41.55M $58.98M -$4.77M -$736K $71.08M -$124.4M
Total Equity $60.99M $52.48M $35.31M $38.82M $41.55M $58.98M -$4.77M -$736K $71.08M -$124.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $49.63M $58.22M $76.96M $93.41M $106.1M $45.86M $22.24M $16.36M
Short-Term Investments $148.8M -- $0 -- -- -- $36.12M --
Cash & Short-Term Investments $198.5M $58.22M $76.96M $93.41M $106.1M $45.86M $58.40M $16.36M
Total Current Assets $203.1M $65.11M $80.59M $95.41M $107.6M $47.16M $61.35M $17.67M
Property, Plant & Equipment, Net $90K $110K $129K $148K $110K $125K $77K $86K
Other Non-Current Assets $2.55M $2.00M $2.06M $1.53M $57K $176K $138K $192K
Total Non-Current Assets $2.64M $2.11M $2.19M $1.68M $167K $301K $215K $278K
Total Assets $205.7M $67.22M $82.78M $97.09M $107.8M $47.46M $61.56M $17.95M
Accounts Payable $14.01M $13.08M $9.99M $5.49M $5.30M $5.02M $4.88M $5.16M
Total Current Liabilities $20.29M $23.65M $20.75M $12.99M $9.17M $9.03M $9.08M $8.58M
Other Non-Current Liabilities $1.66M $1.48M $1.04M -- -- -- -- --
Total Non-Current Liabilities $1.66M $1.48M $1.04M $0 $0 $0 $0 $0
Total Liabilities $21.95M $25.12M $21.79M $12.99M $9.17M $9.03M $9.08M $8.58M
Common Stock $21K $14K $13K $13K $12K $6.0K $6.0K $1.0K
Retained Earnings -$268.8M -$245.5M -$223.4M -$198.6M -$180.9M -$169.7M -$154.0M -$146.8M
Accumulated Other Comp. Income -$54K -$4.0K $3.0K -$6.0K -- -- $11K $1.0K
Total Stockholders' Equity $183.8M $42.10M $60.99M $84.10M $98.61M $38.43M $52.48M $9.37M
Total Equity $183.8M $42.10M $60.99M $84.10M $98.61M $38.43M $52.48M $9.37M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$69.38M -$35.48M -$31.48M -$13.88M -$21.71M -$46.49M -$4.07M -$48.95M -$38.93M -$33.48M
Depreciation & Amortization $64K $39K $9.0K -- $36K $54K $11K $625K $292K $255K
Stock-Based Compensation $6.26M $3.10M $3.28M $4.01M $4.21M $956K $36K $6.87M $4.45M $1.32M
Change in Payables $5.54M $3.02M $271K $207K -$294K -$369K $976K $1.26M $304K $586K
Operating Cash Flow -$50.88M -$30.75M -$28.71M -$8.19M -$16.68M -$18.42M -$2.77M -$34.47M -$31.13M -$29.54M
Capital Expenditure -$116K -$37K -$88K -- -- -- -$162K -$1.97M -$655K -$525K
Free Cash Flow -$51.00M -$30.78M -$28.79M -- -- -- -$2.93M -$36.44M -$31.79M -$30.06M
Purchases of Investments $0 -$35.96M -$9.96M -- -- -- -$51.16M -$70.75M -$70.80M -$23.00M
Investing Cash Flow $36.23M -$35.99M $47K -- -- $3.58M -$162K -$4.19M -$27.71M $24.57M
Common Stock Issued $1.78M $0 -- $7.23M -- $66.70M $551K $661K $507K $10K
Financing Cash Flow $69.36M $51.86M $24.68M $7.24M -$44K $66.67M $4.86M $43.54M $89.26M $2.33M
Net Change in Cash $54.71M -$14.88M -$3.98M -$944K -$16.72M $51.83M $1.92M $4.88M $30.42M -$2.64M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$23.33M -$22.14M -$24.79M -$17.68M -$11.25M -$15.66M -$7.16M -$8.39M
Depreciation & Amortization $20K $19K $19K $17K $15K $13K $10K $10K
Stock-Based Compensation $3.67M $3.18M $1.66M $1.48M $1.50M $1.62M $697K $791K
Change in Payables $388K $3.10M $4.50M $558K -$90K $578K -$714K -$116K
Operating Cash Flow -$22.70M -$18.81M -$16.47M -$14.00M -$10.06M -$10.36M -$10.01M -$8.13M
Capital Expenditure $0 $0 $0 -$55K $0 -$61K -$31K $0
Free Cash Flow -$22.70M -$18.81M -$16.47M -$14.05M -$10.06M -$10.42M -$10.04M -$8.13M
Investing Cash Flow -$147.8M $0 $0 -$55K $0 $36.29M -$35.99M $0
Financing Cash Flow $161.9M $74K $9.0K $1.32M $70.35M -$2.32M $51.88M -$2.0K
Net Change in Cash -$8.59M -$18.73M -$16.46M -$12.73M $60.29M $23.61M $5.88M -$8.13M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -- -11288.9% -254.2% -91775.6% -64673.5%
Net Profit Margin -- -- -- -- -- -- -11302.8% -271.4% -94948.8% -68322.4%
Return on Equity (ROE) -113.7% -67.6% -89.1% -35.8% -52.2% -78.8% -- -- -54.8% --
Return on Assets (ROA) -83.8% -57.6% -80.7% -33.0% -50.1% -75.9% -53.1% -47.5% -42.3% -94.7%
Current Ratio 3.88x 6.76x 10.45x 13.06x 24.19x 26.52x 3.93x 5.91x 5.23x 2.26x
Quick Ratio 3.71x 6.43x 10.13x 12.93x 23.92x 26.01x 11.40x 5.81x 5.12x 2.17x
Debt to Equity -- -- -- -- -- -- -- -- 0.05x --
Revenue Growth (YoY) -- -- -- -- -- -- -99.8% +43890.2% -16.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -47.8% -180.2% -113.7% -61.5% -43.0% -113.8% -67.6% -365.1%
Return on Assets (ROA) -42.7% -112.8% -83.8% -53.3% -39.4% -92.1% -57.6% -190.5%
Current Ratio 10.01x 2.75x 3.88x 7.34x 11.74x 5.22x 6.76x 2.06x
Quick Ratio 9.78x 2.46x 3.71x 7.19x 11.58x 5.08x 6.43x 1.91x
Source: SEC EDGAR CompanyFacts (CIK 0001419041) · from December 31, 2015 Data through June 30, 2026 · synced Nov 20, 2026, 05:25 UTC · Open in terminal